ArticleJournal of theoretical biology2026
Mathematical models for the EP2 and EP4 signaling pathways and their crosstalk.
Article in Journal of theoretical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
G protein-coupled receptors EP2 and EP4 are both activated by the lipid messenger Prostaglandin E2 (PGE2) and induce the intracellular production of cyclic AMP (cAMP), ultimately affecting gene expression. Changes in cellular responses to PGE2 can have important consequences on immunity and disease, yet a detailed understanding of the EP2-EP4 signaling network is lacking. EP2 and EP4 are often co-expressed in cells but their specific contribution to cAMP production is poorly understood. Experimental data have shown that cAMP levels differ depending on whether PGE2 triggers EP2 or EP4, or both. To better understand the underlying mechanisms and predict cellular responses to PGE2, we developed mathematical models for EP2 and EP4 cAMP signaling, including receptor crosstalk. The mathematical models qualitatively reproduce the experimentally observed cAMP levels and provide mechanistic insight into both the differences and commonalities in EP2/EP4 signaling. We found that ligand binding dynamics play a crucial role for both single-receptor signaling and inter-receptor crosstalk. Inhibition of PGE2 signaling via receptor antagonists is gaining increasing attention in tumor immunology. These mathematical models could therefore contribute to the design of more effective anti-tumor therapies targeting EP2 and EP4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.